Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 9 studies | 24% ± 10% |
Insufficient scRNA-seq data for expression of NKD2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 5345.87 | 578 / 578 | 86% | 16.04 | 992 / 1155 |
pancreas | 87% | 285.15 | 285 / 328 | 90% | 15.69 | 161 / 178 |
intestine | 91% | 422.60 | 876 / 966 | 86% | 26.23 | 455 / 527 |
esophagus | 90% | 560.97 | 1301 / 1445 | 79% | 16.07 | 145 / 183 |
bladder | 86% | 492.71 | 18 / 21 | 73% | 17.77 | 369 / 504 |
breast | 73% | 500.08 | 336 / 459 | 80% | 9.85 | 890 / 1118 |
kidney | 99% | 627.81 | 88 / 89 | 49% | 6.87 | 443 / 901 |
prostate | 98% | 817.79 | 240 / 245 | 41% | 2.28 | 206 / 502 |
stomach | 66% | 212.00 | 238 / 359 | 67% | 22.06 | 193 / 286 |
skin | 74% | 738.09 | 1332 / 1809 | 38% | 3.69 | 178 / 472 |
brain | 53% | 172.40 | 1394 / 2642 | 58% | 4.01 | 411 / 705 |
thymus | 80% | 305.57 | 520 / 653 | 29% | 8.07 | 177 / 605 |
adrenal gland | 99% | 596.84 | 255 / 258 | 9% | 0.57 | 21 / 230 |
uterus | 35% | 127.79 | 59 / 170 | 68% | 17.34 | 311 / 459 |
ovary | 27% | 153.04 | 48 / 180 | 75% | 12.83 | 323 / 430 |
spleen | 100% | 1878.06 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.79 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 93% | 13.88 | 42 / 45 |
eye | 0% | 0 | 0 / 0 | 89% | 7.58 | 71 / 80 |
liver | 55% | 181.15 | 124 / 226 | 31% | 3.06 | 125 / 406 |
heart | 78% | 386.38 | 674 / 861 | 0% | 0 | 0 / 0 |
adipose | 50% | 299.01 | 605 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 28% | 1.10 | 8 / 29 |
blood vessel | 16% | 64.62 | 220 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 8% | 32.05 | 78 / 929 | 0% | 0 | 0 / 0 |
muscle | 2% | 3.72 | 14 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0048210 | Biological process | Golgi vesicle fusion to target membrane |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0030178 | Biological process | negative regulation of Wnt signaling pathway |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_0006887 | Biological process | exocytosis |
GO_0010954 | Biological process | positive regulation of protein processing |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0070382 | Cellular component | exocytic vesicle |
GO_0005886 | Cellular component | plasma membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0071944 | Cellular component | cell periphery |
GO_0016328 | Cellular component | lateral plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0032036 | Molecular function | myosin heavy chain binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0019838 | Molecular function | growth factor binding |
GO_0051117 | Molecular function | ATPase binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NKD2 |
Protein name | Protein naked cuticle homolog 2 (Naked-2) (hNkd2) |
Synonyms | |
Description | FUNCTION: Cell autonomous antagonist of the canonical Wnt signaling pathway. May activate a second Wnt signaling pathway that controls planar cell polarity (By similarity). Required for processing of TGFA and for targeting of TGFA to the basolateral membrane of polarized epithelial cells. . |
Accessions | ENST00000274150.4 [Q969F2-2] ENST00000616539.4 [Q969F2-1] ENST00000610777.2 [Q969F2-2] Q969F2 ENST00000296849.10 [Q969F2-1] |